Sole conformal perioperative interstitial brachytherapy of early stage breast carcinoma using high-dose rate afterloading: Longer-term results and toxicity

Reports of Practical Oncology and Radiotherapy

Volumn 13, Issue 2, 2008, Pages 62-68

  Šlampa, Pavel ^a   Ruzickova, Jana ^a   Ondrova, Barbora ^a   Ticha, Hana ^a   Dolezelova, Hana ^a  

^a MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

Author keywords

Breast cancer; Interstitial brachytherapy; Radiotherapy

Indexed keywords

IRIDIUM 192;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; BREAST ABSCESS; BREAST CARCINOMA; BREAST FIBROSIS; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOSIMETRY; ESTHETICS; FEMALE; FOLLOW UP; HEMATOMA; HISTOGRAM; HUMAN; LYMPH NODE METASTASIS; MAMMOGRAPHY; METASTASIS POTENTIAL; MORBIDITY; OUTCOME ASSESSMENT; PARTIAL MASTECTOMY; PATIENT SATISFACTION; PATIENT SELECTION; PERIOPERATIVE PERIOD; PROGNOSIS; RADIATION DERMATITIS; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIATION FIELD; RADIATION INJURY; RADIOISOTOPE THERAPY; RECURRENCE RISK; SCORING SYSTEM; THREE DIMENSIONAL IMAGING; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR VOLUME; VOLUMETRY;

EID: 51349150321     PISSN: 15071367     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1507-1367(10)60083-1     Document Type: Article

References (19)

1. Astrahan MA, Jozsef G, Streeter OE. Optimization of Mammosite therapy. Int J Radiat Oncol Biol Phys 2004; 58: 220-232.
2. Vaidya JS, Tobias JS, Baum M, Keshtgar M, Joseph D, Wenz F et al. Intraoperative radiotherapy for breast cancer. Lancet Oncology 2004; 5: 165-173.
3. Morrow M, White J, Moughan J. Factors predicting the use of breast conserving therapy in stage I and II breast carcinoma. J Clin Oncol 2001; 19: 2254-2262.
4. Rose CM, Recht A. Accelerated partial-breast irradiation (APBI): Let's give it a good test. Int J Radiat Oncol Biol Phys 2004; 57: 1217-1218.
5. Buchholz TA. Partial breast irradiation - is it ready for prime time? Int J Radiat Oncol Biol Phys 2004; 59: 1214-1216.
6. Clark RM, Whelan T, Levine M, Roberts R, Willan A, McCulloch M et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: An update. Ontario Clinical Oncology Group. J Natl Cancer Inst 1996; 88: 1659-1664.
7. Fisher ER, Anderson S, Redmond C, Fisher B et al. Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation: Pathological findings from NSABP protocol B-06. Semin Surg Oncol 1992; 8: 161-166.
8. Polgar C, Strnad V, Major T. Brachytherapy for partial breast irradiation: The European Experience. Semin Rad Oncol 2005; 5: 116-122.
9. Veronesi U, Marubini E, Mariani L, Galimberti V, Luini A, Veronesi P et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: Long-term results of a randomized trial. Ann Oncol 2001; 12: 997-1003.
10. Liljegren GG, Holmberg L, Adami HO, Westman G, Graffman S, Bergh J et al. Sector resection with or without postoperative radiotherapy for stage I breast cancer: Five-year results of a randomized trial. J Natl Cancer Inst 1994; 86: 717-722.
11. Polgar C, Sulyok Z, Fodor J, Orosz Z, Major T, Takáczi-Nagy Z et al. Sole brachyradiotherapy of the tumor bed after conservative surgery for T1 breast cancer: Five-years results of a phase I-II study and initial findings of a randomized phase III trial. J Surg Oncol 2002; 80: 121-128.
12. Perera F, Yu E, Engel J, Holliday R, Scott L, Chisela F et al. Patterns of breast recurrence in a pilot study of brachytherapy confined to the lumpectomy site for early breast cancer with six years'minimum follow-up. Int J Radiat Oncol Biol Phys 2003; 57: 1239-1246.
13. Major T, Polgar C, Fodor J. Dose-volume evaluation of HDR interstitial breast implants planned by tradional and image-based dosimetry systems. Radiother Oncol 2004; 71 (Suppl 2): S39 (Abstract).
14. Ott OJ, Pötter R, Hammer J, Hildebrandt G, Lotter M, Resch A et al. Accelerated partial breast irradiation with 192-iridium multicatheter PDR-/HDR-brachytherapy. Preliminary Results of the German-Austrian Multicenter Trial. Strahlenther Onkol 2004; 180: 642-649.
15. Ott OJ, Hildebrandt G, Pötter R, Hammer J, Lotter M, Resch A et al. Accelerated partial breast irradiation with multi-catheter brachytherapy: Local control, side effects and cosmesis outcome for 274 patients. Results of the German-Austrian multi-centre trial. Radiother Oncol 2007; 82(3): 281-286.
16. Wazer DE, Kaufman S, Cuttino L, DiPetrillo T, Arthur D. Accelerated partial breas irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy. Int J Radiat Oncol Biol Phys 2006; 62: 489-495.
17. Kuske RR, Winter K, Arthur DW, Bolton J, Rabinovitch RA, White JR et al. Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: toxicity analysis of RTOG 95-17. Int J Radiat Oncol Phys 2006; 65: 45-51.
18. Kaufman SA, Dipetrillo TA, Price LL, Midle JB, Wazer DE. Long-term outcome and toxicity in a Phase I/II trial using high-dose-rate multicatheter interstitial brachytherapy for T1/T2 breast cancer. Brachytherapy 2007; 6(4): 286-292.
19. Polgar C, Major T, Fodor J, Németh G, Orosz Z, Sulyok Z et al. High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: seven-year results of a comparative study. Int J Radiat Oncol Biol Phys 2004; 60: 1173-1181.